IRIS

Grob, J., Hamid, O., Wolchok, J., Maio, M., Neyns, B., Thomas, L., et al. (2009). Antitumor responses to ipilimumab in advanced melanoma are not affected by systemic corticosteroids used to manage immune-related adverse events (irAEs). EUROPEAN JOURNAL OF CANCER. SUPPLEMENT, 7(2), 580-580 [10.1016/S1359-6349(09)71956-1].

Antitumor responses to ipilimumab in advanced melanoma are not affected by systemic corticosteroids used to manage immune-related adverse events (irAEs)

Maio M;
2009-01-01
2009
Grob, J., Hamid, O., Wolchok, J., Maio, M., Neyns, B., Thomas, L., et al. (2009). Antitumor responses to ipilimumab in advanced melanoma are not affected by systemic corticosteroids used to manage immune-related adverse events (irAEs). EUROPEAN JOURNAL OF CANCER. SUPPLEMENT, 7(2), 580-580 [10.1016/S1359-6349(09)71956-1].
1.5 Abstract in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/1081042